{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-005029","form_type":"8-K","ticker":"PCSA","cik":"0001533743","company_name":"Processa Pharmaceuticals, Inc.","filed_at":"2024-02-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.529222+00:00","generated_at":"2026-06-06T08:05:46.127409+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Processa regains Nasdaq minimum bid price compliance; delisting risk resolved","bullets":["Received written notice from Nasdaq on Feb 6, 2024 confirming compliance with Listing Rule 5550(a)(2).","Achieved minimum $1.00 closing bid price for 10 consecutive business days ending Feb 2, 2024.","Matter is now closed; no further deficiency or delisting action pending.","Stock ticker PCSA; compliance removal removes immediate delisting overhang."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-005029","json":"https://secwatch.observer/filing/0001493152-24-005029.json","markdown":"https://secwatch.observer/filing/0001493152-24-005029.md","text":"https://secwatch.observer/filing/0001493152-24-005029.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533743/000149315224005029/0001493152-24-005029-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533743/000149315224005029/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T08:05:46.127409+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}